We performed Masson's and SR staining of the myocardium in the IZ, BZ, and RZ myocardium after MI/R injury to evaluate whether hSIRT3 and hTIMP3 gene therapy could improve adverse ventricular remodeling. The gene discussed is SIRT3; the disease is myocardial infarction.